—
C+
C+ The full Closelooknet — membership. Open the C+ overview

Zoetis Inc (ZTS) — chart, structure and Closelooknet read

The Closelooknet read

Zoetis discovers, makes and sells medicines, vaccines, diagnostics and other health products for animals, covering pets such as dogs, cats and horses as well as livestock like cattle, swine and poultry. Its range spans parasite treatments, vaccines, pain and infection drugs, diagnostic instruments and tests, and precision tools for farm management.

Detail below: the desk's view, the earnings record, peers and the company snapshot; daily prices on the price-history tab. Research diary readings, not advice.

Pick a ticker to load its detail page.

Signals for this name

Every Closelooknet reading that exists for ZTS, from the same nightly bakes the boards use. Research diary readings, not advice.

Weather around the name 3 macro readings: Money Temperature, Factor regime, Sovereign pressure

The weather around this name

Macro readings that apply by membership — the regime, the factor tape, the sector cell, the funding backdrop.

  • Money Temperature Composite 47/100 · S&P 500 fund at 48, above its 200-day averageEight instruments scored on position, momentum, volume, volatility and fragility — the regime every name trades inside. Temperature lab → 2026-11-06
  • Factor regime Defensive rotation — low-vol leading, regime-change watchMomentum against low volatility (SPMO / SPLV): below its 50-day trend, 60th percentile of the window, -22.8% over 20 sessions. Factor regime → 2026-11-06
  • Sovereign pressure Index -1.91 · down 2.45 over 21 sessionsG7 long-end yields, 10s30s and the slope — the funding weather for every balance sheet on this site. Sovereign pressure → 2026-11-06
How it trades on rate days beta 0.91 to TLT · on the worst bond days it moved with the market

How it trades on rate days

How ZTS has moved when long-dated Treasury yields rise — measured against TLT, the 20+ year Treasury fund.

  • Beta to long bonds, 1 year 0.91 — moves strongly with bonds for every 1% move in TLT (20+ year Treasuries), Zoetis Inc moved 0.91% on average · correlation 0.23 · higher than 77% of US names
  • Beta, last 3 months 1.36 more rate-sensitive lately than over the year
  • On the 10 worst bond days −0.95% on average against −0.74% for the S&P 500 the 10 sessions of the past year in which TLT fell most, i.e. long yields rose most
  • Latest of those days −1.87% TLT −1.29% that day 2026-09-24

Daily total returns from the adjusted price series; a TLT down day is a day long yields rose. Beta = the average move of the name for a 1% move in TLT. Past sensitivity, not a forecast. An investment diary, not a recommendation.

Who it is priced against Drug Manufacturers - Specialty & Generic · United States · 5 names with week and year-to-date

Peer group

Drug Manufacturers - Specialty & Generic · United States

This name carries no Closelooknet score, so its cohort ranks on trend state — distance to the 50- and 200-day averages — never on a score it does not have.

Compared against ZTS on the nightly bakes; the Peers tab ranks the cohort on the Closelooknet scores where it exists.

Company snapshot — Zoetis Inc

ZTS in five paragraphs: what it makes and sells, where it sits in the Closelooknet stack, who it is priced against, why we track it, what we watch. Research diary, not advice.

What it does
Zoetis discovers, makes and sells medicines, vaccines, diagnostics and other health products for animals, covering pets such as dogs, cats and horses as well as livestock like cattle, swine and poultry. Its range spans parasite treatments, vaccines, pain and infection drugs, diagnostic instruments and tests, and precision tools for farm management. It sells through veterinarians, livestock producers and pet owners worldwide, and is based in Parsippany, New Jersey.
Where it sits in the stack
Zoetis carries no seat in Rubin or Halo, the diary's build-out indices, and sits outside the AI stack our diary tracks. It belongs to the healthcare sector, within animal-health drugs and diagnostics, a sleeve the diary follows separately from the semiconductor and data-centre build-out.
Who it is priced against
The diary holds no peer group for Zoetis; the comparison the market draws is with Elanco Animal Health, the other large listed animal-health maker.
Why Closelooknet tracks it
Zoetis holds a seat in the S&P 500 among the indices the diary tracks, but none in Rubin or Halo. It carries no Closelooknet score, and the diary records no quotes or mentions of it in past editions.
What the diary watches
The diary watches whether Zoetis's shares stabilise after their fall from the year's high, since further weakness would keep the stock away from the diary's usual coverage.

Zoetis Inc (ZTS) trades on US exchanges.

Written from the company’s public profile and Closelooknet’s own readings, 2026-09-17. Descriptive, refreshed with the registry; corrections welcome via the imprint. closelook.net is an investment research diary — market structure, index membership and scores are our own readings, not investment advice. Related: index compare · sector dispersion · scanner.

The Street on this name 3 analyst actions on the wire · latest: price target by Jefferies, 2026-10-20

The Street on this name

Analyst actions and the latest print for ZTS from the Closelooknet wires — third-party opinions on the record, not our readings.

  • Price target Jefferies — target 83 Target set to $83 (+4.3% to spot) 2026-10-20
  • Price target TD Cowen — target 94 Target set to $94 (+21.8% to spot) 2026-08-25
  • Price target Stifel — target 80 from 85 Target cut to $80 from $85 (+4.3% to spot) 2026-08-20

3 actions on the analyst wire since 2026-08-13: 3 target changes. Analyst wire → · Earnings wire →

Dividends and capital return trailing yield 2.67%, quarterly · last 0.53 USD on 2026-10-30

Dividends and capital return

What ZTS pays out and buys back — distributions read from the price series, money terms from the filings.

  • Trailing 12 months 2.12 USD per share · a 2.67% yield on the 2026-11-06 close 4 distributions, paid quarterly 2026-11-06
  • Change on the year +5.7% against the prior twelve months prior twelve months 2.01 USD per share
  • Last distribution 0.53 USD per share as the price series records it, within days of the ex-date 2026-10-30
  • By calendar year 2024: 1.73 USD · 2025: 2.01 USD · 2026: 2.12 USD to date first distribution recorded in the three-year window: 2024-01-18

Per-share amounts are derived from the adjusted price series in the listing currency, so dates sit within days of the ex-date; filing figures come from the fundamentals feed for the last reported fiscal year. An investment diary, not a recommendation.

FAQ · from the current data · as of 2026-11-07

Quick answers

What is Zoetis Inc (ZTS)?

Zoetis Inc trades as ZTS on the US exchange (United States) in the Closelooknet research universe, as of the registry build of 2026-11-07.

Is ZTS in a Closelooknet index?

Not currently — Zoetis Inc is tracked in the Closelooknet research universe but is not a constituent of a Closelooknet functional index as of 2026-11-07.

Where does ZTS trade against its moving averages?

Zoetis Inc trades 5.0% above its 50-day and 14.0% below its 200-day moving average (0.3% below its 20-day). As of 2026-11-06 — a technical state from the nightly Closelooknet bake, not advice. The Technical tab carries the full row.

How does Zoetis Inc compare with its peers?

Against its peer group (Drug Manufacturers - Specialty & Generic · United States), Zoetis Inc (ZTS) sits 39.8% below its 52-week high, 5.0% above its 50-day average; Viatris Inc (VTRS) is 0.3% below, Neurocrine Biosciences Inc (NBIX) is 11.5% below, Elanco Animal Health (ELAN) is 8.0% below, as of 2026-11-06. Put any of them next to ZTS in the chart grid (2×1 or 2×2) and the page lays the companies side by side: performance, trend, valuation, margins and our money-flow reading.

How does Zoetis Inc trade when bond yields rise?

Over the past year Zoetis Inc had a beta of 0.91 to TLT, the long-dated Treasury fund — it moves strongly with bonds, higher than 77% of US names. On the 10 sessions in which long bonds fell most it moved −0.95% on average, against −0.74% for the S&P 500. As of 2026-11-06; The "How it trades on rate days" block on this page carries the lines.

What does Zoetis Inc do?

Zoetis discovers, makes and sells medicines, vaccines, diagnostics and other health products for animals, covering pets such as dogs, cats and horses as well as livestock like cattle, swine and poultry. Its range spans parasite treatments, vaccines, pain and infection drugs, diagnostic instruments and tests, and precision tools for farm management. It sells through veterinarians, livestock producers and pet owners worldwide, and is based in Parsippany, New Jersey. The diary holds no peer group for Zoetis; the comparison the market draws is with Elanco Animal Health, the other large listed animal-health maker. (Company snapshot of 2026-09-17.)

Where does Zoetis Inc sit in the AI build-out?

Zoetis carries no seat in Rubin or Halo, the diary's build-out indices, and sits outside the AI stack our diary tracks. It belongs to the healthcare sector, within animal-health drugs and diagnostics, a sleeve the diary follows separately from the semiconductor and data-centre build-out. Zoetis holds a seat in the S&P 500 among the indices the diary tracks, but none in Rubin or Halo. It carries no Closelooknet score, and the diary records no quotes or mentions of it in past editions. (Company snapshot of 2026-09-17.)

Does Zoetis Inc pay a dividend?

Zoetis Inc has paid 2.12 USD per share over the last twelve months, paid quarterly, a trailing yield of 2.67% on the 2026-11-06 close; the last distribution recorded in the price series was 0.53 USD on 2026-10-30. As of 2026-11-06; the "Dividends and capital return" block on this page carries the lines.

What has Wall Street done on Zoetis Inc recently?

The most recent analyst action on Zoetis Inc on the Closelooknet wire is a price target by Jefferies on 2026-10-20 (target 83). 3 actions on the analyst wire since 2026-08-13: 3 target changes. Analyst actions are third-party opinions recorded by the wire, not Closelooknet readings. The “The Street on this name” block on this page lists the moves; the full feeds are the analyst wire and the earnings wire.

What does this page show?

A live price chart with SMA overlays and drawing tools for ZTS, performance metrics, index-membership context and the Closelooknet structure read — an investment research diary view, not investment advice.

How to use this chart

Toolbar

  • Range — 1M to MAX on daily closes. 1D/5D switch a US stock cell to 5-minute intraday bars; index and foreign cells fall back to 1M daily with a note.
  • Grid — 1×1 up to 2×2. Cells are synchronized: pan or zoom one and the others follow the same dates; the crosshair tracks across all of them. 4 INDICES loads Rubin · HALO · AEI · AW40 side by side.
  • Type / Scale — OHLC, line or area; linear or log price axis.

Picking a series

  • Tap the box in a cell's header to browse every Closelooknet series — headline indices, sub-indices, sectors, layers of all six families — plus the constituents.
  • Or type any ticker (NVDA, 7203.T, ASML.AS …) and press Enter — it charts in the cell straight from our data lake.

Studies

  • Overlays / Oscillators rows toggle the standard set (SMA, Bollinger, RSI, MACD …) per cell.
  • Levels (stock cells) draws the structure engine's support lines — regression bands, pivot cluster, SMA-200, the active fib zone.

Drawing

  • Tap a tool (Trend, Ray, H-Line, Fib, Channel, Rect, Note), then tap the chart once per point — the shape follows your finger or cursor between taps. The chart stops panning while a tool is armed; tap the tool again to release.
  • Drawings save per symbol in this browser and travel between the terminal and the asset page.
  • Delete key removes the selected drawing · Escape cancels a half-placed one · Clear wipes the symbol.

Wave counts

  • Wave places an Elliott count: tap the origin, then each wave end. Press Enter to stop early (inside wave 3 is fine) — dotted ghost targets sketch the remaining waves at guideline ratios.
  • On stocks the scanner's machine count appears automatically in grey — it is fully editable: drag any point, double-tap a label to remove it, Delete to dismiss it for good, Adopt to bring the machine's proposal back.
  • The sequence picker switches 1-5 / A-B-C / A-E / W-X-Y-Z; 1 2 3 cycles the degree; Subdiv starts a one-degree-smaller child count inside a wave.

Sharing

  • Card exports the cell as a branded PNG — chart, drawings and levels exactly as shown.

Related in the Closelooknet universe

then Drug Manufacturers - Specialty & Generic. Scored names rank on their Closelooknet score; names without one rank on trend state — above or below their 50- and 200-day averages — never on a score they do not carry.